Score Your Stock

US stock · figures in US dollars · scored on full-year results

Solventum Solventum Corporation Common Stock

SOLV · Healthcare · Medical Instruments & Supplies
Bottom 43% of scored stocks
OkayBottom 43% of scored stocks

Solventum scores 51/100 on fundamentals: in the bottom 43% of 503 scored S&P 500 stocks. Its strongest area is Risk (75/100); its weakest is Cash & Dividends (25/100).

Best
Risk 75
Weakest
Cash 25

An inexpensively priced stock, but cash & dividends needs attention.

What looks good
What to watch
Mkt capUS$ 13.8b#461 of 503 in the S&P 500EPSUS$ 8.17P/E9.7×✓ vs sector median 30.5×P/B2.9×✓ vs sector median 4×Div yieldNo dividends paidBottom 3% in the S&P 50052w range · 60% of range62.3894.16
as of 31 Oct 2026

Nearby peers

Ranks #35 of 60 in Healthcare by score

#1Universal Health Services79#33Cencora53#34Mettler Toledo51
#35Solventum51
#36Thermo Fisher Scientific51#37Danaher50

One-Minute Summary

Why Solventum scores 51

An inexpensively priced stock, but cash & dividends needs attention.

What looks good
What to watch

Business Strength

70
Why 70?
Pillar score: (2 + 1 + 1 + 2 + 1) = 7 of 10 points → 70
Return on Equity (ROE)30%Strong4-Year Revenue Growth+0%/yrOkay4-Year Profit Growth+2%/yrOkayNet Profit Margin17%StrongQuarterly Momentum-1%Okay
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↑ +6.5%Equity ↓ -58.9%ROE % 29.9%
Net ProfitEquityROE %
1.3b479m1.6b1.4b11.7b3.0b5.0b4.8b202320242025TTM11.5%16.2%30.8%29.9%

Revenue & Net Profit, with Net Margin

Revenue → +1.4%Net Profit ↑ +6.5%Net Margin % 17.3%
RevenueNet ProfitNet Margin %
8.2b8.3b8.3b8.3b1.3b479m1.6b1.4b202320242025TTM16.4%5.8%18.7%17.3%

Sales have been roughly flat for 4 years: the business isn't really growing, just maintaining.

Profit has moved sideways: stable, but not compounding your money faster each year.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +6.1%Net Profit ↓ -24.6%Net Margin % 4.2%
RevenueNet ProfitNet Margin %
2.1b2.1b2.1b2.2b2.1b2.0b2.0b2.2b122m31m137m90m1.3b63m13m92mQ3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'265.9%1.5%6.6%4.2%60.4%3.2%0.6%4.2%
▼▼▼▬▲▲▼▬

Sales have stayed roughly flat over the last 8 quarters.

Profit fell about 24.6% over the last 8 quarters.

Why 50?
Pillar score: (0 + 1 + 2) = 3 of 6 points → 50
Debt-to-Equity1.1×WeakCurrent Ratio1×OkayInterest Coverage7.4×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↓ -36.3%Equity ↓ -58.9%D/E 1.1×
Total DebtEquityD/E
8.3b8.0b5.0b5.3b11.7b3.0b5.0b4.8b202320242025TTM0.7×2.7×1×1.1×

Borrowings fell about 36.3% over 4 years: the company is steadily getting safer.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +48.5%Current Liabilities ↑ +112%Current Ratio 1×
Current AssetsCurrent LiabilitiesCurrent Ratio
2.5b3.2b3.9b3.7b1.7b2.7b3.1b3.7b202320242025TTM1.5×1.2×1.2×1×
Why 25?
Pillar score: (0 + 1 + 0 + 1) = 2 of 8 points → 25
Dividend QualityNo dividends paidWeak
Payout ratio: 0%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowNegative recentlyWeakCash & Cash EquivalentsPartly healthyOkay
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↓ -89.1%Free CF ↓ -107.3%
Operating CFFree CF
1.9b1.2b369m209m1.6b805m-10m-118m202320242025TTM

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↑ +107.7%Total Debt ↓ -36.3%
CashTotal Debt
194m762m878m403m8.3b8.0b5.0b5.3b202320242025TTM

Dividends per Share, with Yield

DPS (cents) → +0%Yield % 0%
DPS (cents)Yield %
000020222023202420250%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 33?
Pillar score: (2 + 0 + 0) = 2 of 6 points → 33
P/E Ratio9.7×StrongP/B Ratio2.9×WeakPEG Ratio4.5Weak
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 91.69US$ 77.22US$ 62.76Oct '25Feb '26Jun '26Oct '26

The share price is up about 17.8% over the past year.

Why 75?
Pillar score: (1 + 2 + 2 + 1 + 1 + 2) = 9 of 12 points → 75
Earnings ConsistencyUnevenOkayDebt Trend (4yr)FallingStrongShare Count Trend (4yr)-1%/yrStrongInventory vs Sales (4yr)+6.2 pp/yr vs salesOkayAsset Turnover Trend (4yr)-0.8%OkayQuarterly Consistency1 of 4 quarters downStrong
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue → +1.4%Inventory ↑ +21.4%Inv. % of Rev. 12.5%
RevenueInventoryInv. % of Rev.
8.2b8.3b8.3b8.3b857m965m1.1b1.0b202320242025TTM10.5%11.7%12.8%12.5%
Ranks #35 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#33Cencora53#34Mettler Toledo51
#35Solventum (you)51
#36Thermo Fisher Scientific51#37Danaher50

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 8.3bUS$ 1.4bUS$ 209.0mUS$ -118.0mUS$ -327.0mUS$ 403.0mUS$ 5.3bUS$ 506.0mUS$ 4.8bUS$ 3.7bUS$ 3.7bUS$ 14.2bUS$ 9.4bUS$ 1.0b-30%17%1.1×1.0×7.4×----
2025US$ 8.3bUS$ 1.6bUS$ 369.0mUS$ -10.0mUS$ -379.0mUS$ 878.0mUS$ 5.0b-US$ 5.0bUS$ 3.9bUS$ 3.1bUS$ 14.3bUS$ 9.2bUS$ 1.1bUS$ 0.0m31%19%1.0×1.2×5.9×0%8.8×2.7×1.8
2024US$ 8.3bUS$ 479.0mUS$ 1.2bUS$ 805.0mUS$ -380.0mUS$ 762.0mUS$ 8.0bUS$ 200.0mUS$ 3.0bUS$ 3.2bUS$ 2.7bUS$ 14.5bUS$ 11.5bUS$ 965.0mUS$ 0.0m16%6%2.7×1.2×2.7×0%24.2×3.9×-
2023US$ 8.2bUS$ 1.3bUS$ 1.9bUS$ 1.6bUS$ -290.0mUS$ 194.0mUS$ 8.3b-US$ 11.7bUS$ 2.5bUS$ 1.7bUS$ 13.9bUS$ 2.3bUS$ 857.0mUS$ 0.0m12%16%0.7×1.5×999.0×----